Clinical trial
A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
NCT05561751 is registered in ClinicalTrials.gov with GPCR Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
- Lead sponsor
- GPCR Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 13, 2023
- Completion date
- October 31, 2025
- Enrollment
- 30 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.